Literature DB >> 21353223

Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study.

Anna M Kucharska-Newton1, Keri L Monda, Stephen Campbell, Patrick T Bradshaw, Lynne E Wagenknecht, Eric Boerwinkle, Bruce A Wasserman, Gerardo Heiss.   

Abstract

OBJECTIVES: Platelet activation and aggregation play an important role in the pathogenesis of cardiovascular disease. We examined the association of a single nucleotide polymorphism (SNP) in the GPIIIa platelet glycoprotein (Leu33Pro) with carotid artery plaque morphology and with expression of platelet markers using data from the Atherosclerosis Risk in Communities (ARIC) Carotid MRI study.
METHODS: The study sample consisted of 1202 Caucasian members of the ARIC study cohort recruited in 2004-2005 to participate in the Carotid MRI Substudy under stratified sampling based on maximum carotid artery wall thickness. The Leu33Pro polymorphism was identified as SNP rs5918 in the ITGB3 gene. Plaque visualization was accomplished with contrast enhanced MRI examination of the thickest segment of the carotid artery. Expression of platelet markers was measured using fasting whole blood flow cytometry.
RESULTS: This cross-sectional analysis based on age and gender adjusted weighted linear regression models suggests that those homozygous for the Leu33Pro risk allele (C) have decreased mean and minimum fibrous cap thickness. We did not observe differences in plaque lipid volume or maximum carotid artery wall thickness across SNP rs5918 genotypes. Carriers of the Leu33Pro polymorphism, as compared to major allele homozygotes, had greater percent of platelets expressing P-selectin, a platelet glycoprotein indicating activation status. Prevalent coronary heart disease did not affect estimates of fibrous cap thickness or of platelet activation.
CONCLUSION: Our results suggest that individuals with Leu33Pro polymorphism of the GPIIIa glycoprotein may be predisposed to increased risk of atherosclerotic plaque rupture.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353223      PMCID: PMC3089705          DOI: 10.1016/j.atherosclerosis.2011.01.038

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  29 in total

Review 1.  Structure and function of the platelet integrin alphaIIbbeta3.

Authors:  Joel S Bennett
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 2.  A review of clinical trials with eptifibatide in cardiology.

Authors:  Uwe Zeymer; Harm Wienbergen
Journal:  Cardiovasc Drug Rev       Date:  2007

3.  Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction.

Authors:  A J Marian; R Brugada; N S Kleiman
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

Review 4.  Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.

Authors:  B S Coller
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): no association with platelet fibrinogen binding.

Authors:  D J Meiklejohn; S J Urbaniak; M Greaves
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

6.  Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease.

Authors:  A H Goodall; N Curzen; M Panesar; C Hurd; C J Knight; W H Ouwehand; K M Fox
Journal:  Eur Heart J       Date:  1999-05       Impact factor: 29.983

7.  Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly.

Authors:  J Mikkelsson; M Perola; P Laippala; V Savolainen; J Pajarinen; K Lalu; A Penttilä; P J Karhunen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-10       Impact factor: 8.311

8.  Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

Authors:  B Savage; E Saldívar; Z M Ruggeri
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

9.  Platelet alloantigens HPA-1, -2, -3, -5 and -6b in Finns.

Authors:  S Kekomäki; J Partanen; R Kekomäki
Journal:  Transfus Med       Date:  1995-09       Impact factor: 2.019

Review 10.  Adhesion mechanisms in platelet function.

Authors:  Zaverio M Ruggeri; G Loredana Mendolicchio
Journal:  Circ Res       Date:  2007-06-22       Impact factor: 17.367

View more
  14 in total

1.  Lack of association between integrin αvβ3 gene polymorphisms and hemorrhagic fever with renal syndrome in Han Chinese from Hubei, China.

Authors:  Xiao-Ping Chen; Hai-Rong Xiong; Ni Zhu; Qing-Zhou Chen; Hui Wang; Chao-Jie Zhong; Mei-Rong Wang; Shuang Lu; Fan Luo; Wei Hou
Journal:  Virol Sin       Date:  2017-02-09       Impact factor: 4.327

Review 2.  Genetically Determined Platelet Reactivity and Related Clinical Implications.

Authors:  Teresa Strisciuglio; Giuseppe Di Gioia; Chiara De Biase; Massimiliano Esposito; Danilo Franco; Bruno Trimarco; Emanuele Barbato
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-05-19

Review 3.  Atherosclerosis, inflammation, genetics, and stem cells: 2012 update.

Authors:  Pascal J Goldschmidt-Clermont; Chunming Dong; David M Seo; Omaida C Velazquez
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

4.  A novel ultrasonic method for evaluation of blood clotting parameters.

Authors:  Vacis Tatarunas; Algirdas Voleisis; Reimondas Sliteris; Rymantas Kazys; Liudas Mazeika; Vaiva Lesauskaite
Journal:  J Med Ultrason (2001)       Date:  2018-03-13       Impact factor: 1.314

5.  Are centenarians genetically predisposed to lower disease risk?

Authors:  Jonatan R Ruiz; Carmen Fiuza-Luces; Amaya Buxens; Amalia Cano-Nieto; Félix Gómez-Gallego; Catalina Santiago; Gabriel Rodríguez-Romo; Nuria Garatachea; José I Lao; María Morán; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2011-09-06

6.  Genetic association analysis of ITGB3 polymorphisms with age at onset of schizophrenia.

Authors:  Ke-Sheng Wang; Xuefeng Liu; Tania Bedard Arana; Nicholas Thompson; Henry Weisman; Cecilia Devargas; Chunxiang Mao; Brenda Bin Su; Cynthia Camarillo; Michael A Escamilla; Chun Xu
Journal:  J Mol Neurosci       Date:  2013-07-17       Impact factor: 3.444

7.  Association of platelet ITGA2B and ITGB3 polymorphisms with ex vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects.

Authors:  Mu-Peng Li; Yan Xiong; An Xu; Ji-Peng Zhou; Jie Tang; Zan-Ling Zhang; Hong-Hao Zhou; Wei Zhang; Xiao-Ping Chen
Journal:  Int J Hematol       Date:  2014-01-29       Impact factor: 2.490

8.  Resilience to orthostasis and haemorrhage: A pilot study of common genetic and conditioning mechanisms.

Authors:  Dmitry M Davydov; Renad I Zhdanov; Vladimir G Dvoenosov; Olga A Kravtsova; Elena N Voronina; Maxim L Filipenko
Journal:  Sci Rep       Date:  2015-05-29       Impact factor: 4.379

Review 9.  The platelet fibrinogen receptor: from megakaryocyte to the mortuary.

Authors:  Christopher N Floyd; Albert Ferro
Journal:  JRSM Cardiovasc Dis       Date:  2012-05-31

10.  The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis.

Authors:  Christopher N Floyd; Agnesa Mustafa; Albert Ferro
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.